Detailed Summary
Overview of the current peptide trend and the critical lack of human evidence for many compounds. The goal is to separate marketing claims from clinical data across four main categories: regenerative, neurological, growth hormone, and aesthetic peptides.
Joint and Regenerative Peptides (01:15 - 09:44)
- Thymosin Beta 4 (TB4): Naturally occurring in platelets and the thymus. While animal studies show 60% faster wound healing, human data is limited to eye health, where it helps with dry eye and corneal wounds. It is proven safe in humans at various doses.
- Thymosin Alpha 1: A potent immune modulator approved in 35 countries. It enhances T-cell output and vaccine response in the elderly, though it does not structurally regrow the thymus.
- BPC-157: Derived from stomach protein, it is highly popular for tendon and ligament repair. However, there are zero completed human clinical trials; all evidence is based on rodents or anecdotes.
Brain and Mitochondrial Peptides (10:43 - 24:30)